Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Kaj Blennow Niklas Mattsson Oskar Hansson |
| Publication date | April 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |